'On consolidated basis

Quarter ended September 2025 compared with Quarter ended September 2024.

Net sales (including other operating income) of Zydus Wellness has increased 31.97% to Rs 650.5 crore.  Operating profit margin has declined from 3.98% to 3.54%, leading to 17.35% rise in operating profit to Rs 23.00 crore.  Raw material cost as a % of total sales (net of stock adjustments) decreased from 45.40% to 40.18%.   Purchase of finished goods cost rose from 2.92% to 6.73%.   Employee cost decreased from 11.46% to 10.24%.   Other expenses rose from 35.92% to 39.30%.   Selling and administration expenses rose from 13.92% to 14.42%.   

Other income fell 65% to Rs 1.4 crore.  PBIDT rose 3.39% to Rs 24.4 crore.  Provision for interest rose 1,644.44% to Rs 15.7 crore.  Loan funds rose to Rs 3,042.00 crore as of 30 September 2025 from Rs 154.10 crore as of 30 September 2024.  Inventories rose to Rs 611.90 crore as of 30 September 2025 from Rs 350.90 crore ...

• 

  (05-Feb-2025)

  Castrol India

  Expects EBITDA margin of 22%-25% for CY25
• 

  (10-Feb-2023)

  Deepak Nitrite

  Plans capex of about Rs 1500 crore for FY23 and FY24
• 

  (09-Feb-2023)

  Mayur Uniquoters

  Targets revenue of Rs 1000 crore in FY24
• 

  (31-Jan-2023)

  Tega industries

  Capex plan is US$ 30-32 million for next three years